Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Capital Leases (2016 - 2018)

Historic Capital Leases for Wave Life Sciences (WVE) over the last 4 years, with Q4 2018 value amounting to $9.2 million.

  • Wave Life Sciences' Capital Leases rose 19886.88% to $9.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $9.2 million, marking a year-over-year increase of 19886.88%. This contributed to the annual value of $9.2 million for FY2018, which is 19886.88% up from last year.
  • Per Wave Life Sciences' latest filing, its Capital Leases stood at $9.2 million for Q4 2018, which was up 19886.88% from $8.2 million recorded in Q3 2018.
  • Over the past 5 years, Wave Life Sciences' Capital Leases peaked at $9.2 million during Q4 2018, and registered a low of $31000.0 during Q3 2016.
  • For the 4-year period, Wave Life Sciences' Capital Leases averaged around $2.6 million, with its median value being $1.6 million (2017).
  • In the last 5 years, Wave Life Sciences' Capital Leases plummeted by 6702.13% in 2016 and then skyrocketed by 665161.29% in 2017.
  • Wave Life Sciences' Capital Leases (Quarter) stood at $78000.0 in 2015, then skyrocketed by 48.72% to $116000.0 in 2016, then soared by 2567.24% to $3.1 million in 2017, then surged by 198.87% to $9.2 million in 2018.
  • Its Capital Leases was $9.2 million in Q4 2018, compared to $8.2 million in Q3 2018 and $6.5 million in Q2 2018.